Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mechanisms to improve chemotherapy effectiveness.

R C Young1

  • 1Fox Chase Cancer Center, Philadelphia, PA 19111.

Cancer
|February 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The sounds of silence.

Nature·2000
Same author

Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancer.

American journal of reproductive immunology (New York, N.Y. : 1989)·2000
Same author

Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Journal of the National Medical Association·2000
Same author

Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF.

American journal of reproductive immunology (New York, N.Y. : 1989)·2000
Same author

Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program.

The oncologist·2000
Same author

Three cycles versus six cycles of adjuvant paclitaxel (Taxol)/carboplatin in early stage ovarian cancer.

Seminars in oncology·2000

Overcoming drug resistance in cancer therapy is crucial. Optimizing chemotherapy dose intensity and utilizing novel drug delivery systems can significantly improve patient survival rates.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Therapeutics

Background:

  • Chemotherapy's curative potential is limited by drug resistance, poor drug access, and unfavorable pharmacokinetics.
  • Drug resistance can be intrinsic, acquired, or induced, affecting single or multiple agents (pleiotropic).

Purpose of the Study:

  • To review the mechanisms of drug resistance and strategies for overcoming it.
  • To highlight the significance of dose intensity and novel drug delivery in cancer treatment.

Main Methods:

  • Review of existing literature on drug resistance mechanisms.
  • Analysis of retrospective and prospective studies on dose intensity.
  • Examination of emerging drug delivery techniques.

Main Results:

Related Experiment Videos

  • Dose intensity has been identified as an independent factor for improved survival in various cancers.
  • Novel drug delivery methods like regional infusion and continuous infusion show promise.

Conclusions:

  • Optimizing dose intensity is critical for enhancing chemotherapy efficacy.
  • Advanced drug delivery systems can improve the effectiveness of existing and future anti-cancer agents.